Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease
Year: 2003
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Circulation
Authors: Nikolaus Marx, Armin Imhof, Johannes Froehlich, Laila Siam, Jochen Ittner, Gerhard Wierse, Arnold Schmidt, Winfried Maerz, Vinzenz Hombach, Wolfgang Koenig
Institutions: University of Freiburg, Universität Ulm
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Award: G59302984
OpenAlex ID: W2008674682
